학술논문

Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation
Document Type
Article
Source
In: Clinical Pharmacokinetics. (Clinical Pharmacokinetics, April 2024, 63(4):511-527)
Subject
Language
English
ISSN
11791926
03125963